Members of the peroxisome proliferator-activated receptors (PPARs) regulate important transcriptional programs to maintain metabolic homeostasis and as such are current and prospective therapeutic targets to treat metabolic diseases. Our long-term goal is to understand the regulatory mechanisms in each of the metabolically active tissues through which PPAR? (also referred to as PPAR?) controls metabolism. Previous studies have suggested that this receptor increases fatty acid ?-oxidation in peripheral tissues to prevent diet-induced obesity. Using mouse models of insulin resistance, our results have identified the liver as an additional site of PPAR? action in regulating glucose and fatty acid metabolism as well as insulin sensitivity. In contrast to its activity in the periphery, we found that PPAR? activation lowers glucose levels through regulation of glucose utilization pathways, including glycogen and fatty acid synthesis. The hypothesis behind this proposal is that PPARd plays an important role in controlling hepatic lipid and carbohydrate metabolism through a three-step energy substrate switching mechanism, in which it promotes glucose utilization in liver for the synthesis of glycogen and fatty acids. The newly made lipids are subsequently delivered by VLDL and utilized in the periphery.
The specific aims are designed to determine the molecular mechanisms by which PPAR? regulates these processes, which should identify novel therapeutic pathways to control the progression of metabolic diseases, such as insulin resistance.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Laughlin, Maren R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard University
Schools of Public Health
United States
Zip Code
McCarthy, Ryan C; Lu, Dah-Yuu; Alkhateeb, Ahmed et al. (2016) Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta. J Neuroinflammation 13:21
Jacobi, David; Liu, Sihao; Burkewitz, Kristopher et al. (2015) Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness. Cell Metab 22:709-20
Knudsen, Nelson H; Lee, Chih-Hao (2014) IL-21 and IRF4: A complex partnership in immune and metabolic regulation. Diabetes 63:1838-40
Liu, Sihao; Alexander, Ryan K; Lee, Chih-Hao (2014) Lipid metabolites as metabolic messengers in inter-organ communication. Trends Endocrinol Metab 25:356-63
Liu, Sihao; Reilly, Shannon M; Lee, Chih-Hao (2013) Transcriptional repression of mitochondrial function in aging: a novel role for the silencing mediator of retinoid and thyroid hormone receptors co-repressor. Antioxid Redox Signal 19:299-309
Kim, Jonghan; Jia, Xuming; Buckett, Peter D et al. (2013) Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia. FASEB J 27:1657-63
Knudsen, Nelson H; Lee, Chih-Hao (2013) STAT4: an initiator of meta-inflammation in adipose tissue? Diabetes 62:4002-3
Liu, Sihao; Brown, Jonathan D; Stanya, Kristopher J et al. (2013) A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Nature 502:550-4
Jia, Xuming; Kim, Jonghan; Veuthey, Tania et al. (2013) Glucose metabolism in the Belgrade rat, a model of iron-loading anemia. Am J Physiol Gastrointest Liver Physiol 304:G1095-102
Caradonna, Kacey L; Engel, Juan C; Jacobi, David et al. (2013) Host metabolism regulates intracellular growth of Trypanosoma cruzi. Cell Host Microbe 13:108-17

Showing the most recent 10 out of 20 publications